There are other anti-EGFR antibodies under investigation for use in combination with chemo- and radio-therapy for oral cancer treatment such as zalutumumab, panitumumab and nimotuzumab [76]. The gene discussed is EGFR; the disease is lip and oral cavity carcinoma.